These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels. Biermasz NR; Dulken HV; Roelfsema F Clin Endocrinol (Oxf); 2000 Sep; 53(3):321-7. PubMed ID: 10971449 [TBL] [Abstract][Full Text] [Related]
7. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure. Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204 [TBL] [Abstract][Full Text] [Related]
8. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082 [TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Holdaway IM; Bolland MJ; Gamble GD Eur J Endocrinol; 2008 Aug; 159(2):89-95. PubMed ID: 18524797 [TBL] [Abstract][Full Text] [Related]
10. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly. Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288 [TBL] [Abstract][Full Text] [Related]
11. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Fieffe S; Morange I; Petrossians P; Chanson P; Rohmer V; Cortet C; Borson-Chazot F; Brue T; Delemer B; Eur J Endocrinol; 2011 Jun; 164(6):877-84. PubMed ID: 21464140 [TBL] [Abstract][Full Text] [Related]
12. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. Colao A; Pivonello R; Grasso LF; Auriemma RS; Galdiero M; Savastano S; Lombardi G Eur J Endocrinol; 2011 Nov; 165(5):713-21. PubMed ID: 21868601 [TBL] [Abstract][Full Text] [Related]
13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment. Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555 [TBL] [Abstract][Full Text] [Related]
14. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Baldwin A; Cundy T; Butler J; Timmis AD Acta Endocrinol (Copenh); 1985 Jan; 108(1):26-30. PubMed ID: 3969807 [TBL] [Abstract][Full Text] [Related]
15. Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus. Arihara Z; Sakurai K; Yamada S; Murakami O; Takahashi K Tohoku J Exp Med; 2008 Dec; 216(4):325-9. PubMed ID: 19060447 [TBL] [Abstract][Full Text] [Related]
16. GH and mortality in acromegaly. Sheppard MC J Endocrinol Invest; 2005; 28(11 Suppl International):75-7. PubMed ID: 16625851 [TBL] [Abstract][Full Text] [Related]
17. Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms? Stelmachowska-Banaś M; Zdunowski P; Zgliczyński W Endokrynol Pol; 2009; 60(1):20-4. PubMed ID: 19224501 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Bogazzi F; Colao A; Rossi G; Lombardi M; Urbani C; Sardella C; Iannelli A; Scattina I; Manetti L; Del Sarto S; Pivonello R; Grasso LF; Lupi I; Auriemma RS; Lombardi G; Martino E Eur J Endocrinol; 2013 Sep; 169(3):367-76. PubMed ID: 23828855 [TBL] [Abstract][Full Text] [Related]
20. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly. Petrossians P; Tichomirowa MA; Stevenaert A; Martin D; Daly AF; Beckers A Ann Endocrinol (Paris); 2012 Jun; 73(3):190-201. PubMed ID: 22682917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]